Emerald Mutual Fund Advisers Trust Madrigal Pharmaceuticals, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.47 Billion
- Q2 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 36,920 shares of MDGL stock, worth $16.1 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
36,920
Previous 35,238
4.77%
Holding current value
$16.1 Million
Previous $11.7 Million
4.27%
% of portfolio
0.76%
Previous 0.95%
Shares
9 transactions
Others Institutions Holding MDGL
# of Institutions
356Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$958 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$913 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$871 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$863 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$820 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.47B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...